#ACR21 Abst#0455 ARIAA Study: Abatacept for subclinical arthritis ⭐️ ACPA + arthralgia + MRI inflammation 🔥 ⭐️ ⬇️ MRI inflam (primary) and ⬇️ progression to arthritis (secondary) ▶️ Many patients likely early RA, would still rec starting MTX 1st https://t.co/4aREvqlpUI @Rheumnow https://t.co/vqRgsd75Il